Perspective Therapeutics Statistics
Total Valuation
CATX has a market cap or net worth of $553.72 million. The enterprise value is $415.65 million.
Important Dates
The last earnings date was Monday, March 16, 2026, after market close.
| Earnings Date | Mar 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CATX has 113.93 million shares outstanding. The number of shares has increased by 14.57% in one year.
| Current Share Class | 113.93M |
| Shares Outstanding | 113.93M |
| Shares Change (YoY) | +14.57% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.57% |
| Owned by Institutions (%) | 30.38% |
| Float | 74.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 630.24 |
| Forward PS | 980.63 |
| PB Ratio | 1.78 |
| P/TBV Ratio | 3.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 470.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.17, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.17 |
| Quick Ratio | 5.08 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -302.03 |
Financial Efficiency
Return on equity (ROE) is -41.65% and return on invested capital (ROIC) is -28.11%.
| Return on Equity (ROE) | -41.65% |
| Return on Assets (ROA) | -23.35% |
| Return on Invested Capital (ROIC) | -28.11% |
| Return on Capital Employed (ROCE) | -47.66% |
| Weighted Average Cost of Capital (WACC) | 14.09% |
| Revenue Per Employee | $5,325 |
| Profits Per Employee | -$621,211 |
| Employee Count | 166 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -793,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +86.92% in the last 52 weeks. The beta is 1.80, so CATX's price volatility has been higher than the market average.
| Beta (5Y) | 1.80 |
| 52-Week Price Change | +86.92% |
| 50-Day Moving Average | 4.28 |
| 200-Day Moving Average | 3.52 |
| Relative Strength Index (RSI) | 48.79 |
| Average Volume (20 Days) | 1,710,328 |
Short Selling Information
The latest short interest is 9.64 million, so 8.47% of the outstanding shares have been sold short.
| Short Interest | 9.64M |
| Short Previous Month | 9.54M |
| Short % of Shares Out | 8.47% |
| Short % of Float | 13.00% |
| Short Ratio (days to cover) | 1.42 |
Income Statement
In the last 12 months, CATX had revenue of $884,000 and -$103.12 million in losses. Loss per share was -$1.40.
| Revenue | 884,000 |
| Gross Profit | -83.33M |
| Operating Income | -113.56M |
| Pretax Income | -104.43M |
| Net Income | -103.12M |
| EBITDA | -110.32M |
| EBIT | -113.56M |
| Loss Per Share | -$1.40 |
Full Income StatementBalance Sheet
The company has $144.74 million in cash and $3.25 million in debt, with a net cash position of $141.48 million or $1.24 per share.
| Cash & Cash Equivalents | 144.74M |
| Total Debt | 3.25M |
| Net Cash | 141.48M |
| Net Cash Per Share | $1.24 |
| Equity (Book Value) | 207.03M |
| Book Value Per Share | 2.78 |
| Working Capital | 119.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$82.48 million and capital expenditures -$12.75 million, giving a free cash flow of -$95.23 million.
| Operating Cash Flow | -82.48M |
| Capital Expenditures | -12.75M |
| Free Cash Flow | -95.23M |
| FCF Per Share | -$0.84 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -12,846.61% |
| Pretax Margin | -11,813.12% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CATX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.57% |
| Shareholder Yield | -14.57% |
| Earnings Yield | -18.51% |
| FCF Yield | -17.09% |
Analyst Forecast
The average price target for CATX is $12.00, which is 146.91% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 146.91% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 211.20% |
| EPS Growth Forecast (5Y) | -17.40% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 17, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 17, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
CATX has an Altman Z-Score of -0.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.41 |
| Piotroski F-Score | 2 |
